Identification | Back Directory | [Name]
FMOC-ARG(BOC)2-OH | [CAS]
143824-77-5 | [Synonyms]
Fmoc-Arg(Boc) FMOC-ARG(BOC)2-OH FMOC-L-ARG(BOC)2-OH L-Fmoc-Arg(Boc)2-OH FMOC-ARGININE(BOC)2-OH n-alpha-fmoc-ng,ng-diboc FMOC-ARG(BOC)2-OH USP/EP/BP N-Fmoc-Ng,Ng-diBoc-L-arginine N2-Fmoc-N5,5'-Di-Boc-Arginine N-Fmoc-N',N''-diBoc-L-arginine Nα-Fmoc-Nω,Nω'-bis-Boc-L-arginine N-ALPHA-FMOC-NG,NG-DIBOC-L-ARGININE N-ALPHA-FMOC-N',N''-BIS-BOC-L-ARGININE FMOC-N-OMEGA,N-OMEGA'-BIS-BOC-L-ARGININE N^w,N^w'-Di-Boc-N^a-FMoc-L-arginine, 95% Nomega,Nomega'-Di-Boc-Nalpha-Fmoc-L-arginine Nα-Fmoc-Nω,Nω'-bis-Boc-L-arginine≥ 95% (HPLC) (9H-Fluoren-9-yl)MethOxy]Carbonyl Arg(Boc)2-OH (Symmetrical) N-ALPHA-FMOC-N-OMEGA,N-OMEGA'-BIS-T-BUTOXYCARBONYL-L-ARGININE (S)-5-[[Bis(Boc-amino)methylene]amino]-2-(Fmoc-amino)pentanoic Acid N-α-(9-fluorenylmethyloxycarbonyl)-N-ω′,N-ω″-bis-tert-butyloxycarbonyl-L-argine N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N'',N''-BIS-T-BUTYLOXYCARBONYL-L-ARGININE N-ALPHA-(9-FLUORENYLMETHYLOXYCARBONYL)-N',N''-BIS-TERT-BUTYLOXYCARBONYL-L-ARGININE N-ALPHA-(9-FLUORENYLMETHOXYCARBONYL)-N-OMEGA1,N-OMEGA2-DI-T-BUTOXYCARBONYL-L-ARGININE (2S)-5-{[bis({[(tert-butoxy)carbonyl]amino})methylidene]amino}-2-({[(9H-fluoren-9-yl)methoxy]carbonyl}amino)pentanoic acid (S,E)-10-(tert-butoxycarbonylamino)-1-(9H-fluoren-9-yl)-14,14-dimethyl-3,12-dioxo-2,13-dioxa-4,9,11-triazapentadec-10-ene-5-carboxylic acid (S)-2-((((9H-Fluoren-9-yl)methoxy)carbonyl)amino)-5-((2,2,10,10-tetramethyl-4,8-dioxo-3,9-dioxa-5,7-diazaundecan-6-ylidene)amino)pentanoic acid 11-Oxa-2,7,9-triazatridec-7-enoic acid, 3-carboxy-8-[[(1,1-dimethylethoxy)carbonyl]amino]-12,12-dimethyl-10-oxo-, 1-(9H-fluoren-9-ylmethyl) ester, (3S)- | [Molecular Formula]
C31H40N4O8 | [MDL Number]
MFCD00237008 | [MOL File]
143824-77-5.mol | [Molecular Weight]
596.67 |
Hazard Information | Back Directory | [Chemical Properties]
White to off-white powder | [Uses]
Fmoc-Arg(Boc)2-OH is an intermediate used in membrane enhanced peptide synthesis. |
|
|